• Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (1)
    • Targeting the PIM protein kinases for the treatment of a T-cell acute lymphoblastic leukemia subset.
    • See All Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

Targeting the PIM protein kinases for the treatment of a T-cell acute lymphoblastic leukemia subset.

Targeting the PIM protein kinases for the treatment of a T-cell acute lymphoblastic leukemia subset. Oncotarget. 2017 May 02; 8(18):30199-30216.

View in: PubMed

subject areas
  • Amyloid Precursor Protein Secretases
  • Animals
  • Antineoplastic Agents
  • Biomarkers
  • Cell Line, Tumor
  • Cell Proliferation
  • Cell Survival
  • Disease Models, Animal
  • Drug Resistance, Neoplasm
  • Drug Synergism
  • Drug Therapy, Combination
  • Female
  • Gene Expression Profiling
  • Humans
  • Mice
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
  • Protein Kinase Inhibitors
  • Proteomics
  • Proto-Oncogene Proteins c-pim-1
  • Xenograft Model Antitumor Assays

authors with profiles
  • Shikhar Mehrotra
  • Andrew S Kraft